MarketPulse

book-to-bill ratio

19 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misstatements on Financial Metrics

$MEDP faces class action lawsuit alleging executives misrepresented book-to-bill ratio; investors must act by June 5, 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

MEDP Stock Plunges 15.9% on Guidance Misstatement; Securities Fraud Lawsuit Filed

Medpace Holdings faces securities lawsuit over allegedly inflated Q4 2025 guidance. Stock dropped 15.9% after actual book-to-bill ratio fell short of management projections.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Medpace Faces Securities Lawsuit Over Backlog Claims; June 8 Deadline Looms

Medpace faces securities lawsuit alleging false backlog statements. Investors have until June 8, 2026 to join class action claiming overstated growth expectations.
MEDPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Allegedly Misleading Book-to-Bill Statements

Class action lawsuit filed against Medpace Holdings alleging executives made false statements about book-to-bill ratio from April 2025 to February 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

NOV Navigates Middle East Disruptions as Energy Cycle Recovery Looms

NOV reports Q1 2026 revenue decline to $2.05B amid Middle East disruptions; management expects undersupplied market recovery ahead.
NOVbook-to-bill ratioAdjusted EBITDA
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Medpace Securities Lawsuit Alleges False Backlog Claims; June 8 Deadline Looms

Rosen Law Firm notifies $MEDP investors of securities class action over alleged misstatements regarding backlog cancellation rates between April 2025 and February 2026.
MEDPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Hit With Class Action Over Inflated Book-to-Bill Claims

Medpace faces class action lawsuit over allegedly inflated book-to-bill ratio claims during April 2025-February 2026 period; lead plaintiff deadline set for June 5, 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misleading Book-to-Bill Claims

Class action lawsuit filed against $MDPC alleging executives overstated book-to-bill ratio at approximately 1.15 despite contrary internal data from April 2025 to February 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Gross Law Firm

Medpace Hit With Securities Lawsuit Over Backlog Misstatements

Medpace faces class action suit alleging false guidance on cancellation rates. Stock plunged 15.9% after Q4 2025 miss, triggering investor claims.
MEDPstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Medpace Stock Plunges 15.9% After Book-to-Bill Miss; Class Action Filed

Robbins LLP filed class action lawsuit against $MEDP for allegedly misleading investors about book-to-bill guidance, triggering 15.9% stock decline.
MEDPclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Medpace Stock Plunges 16% as Securities Lawsuit Alleges Guidance Misstatements

Robbins Geller files class action against $MEDP over alleged false book-to-bill projections. Stock fell 16% after Q4 miss. Lead plaintiff deadline: June 8, 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misstatements on Book-to-Bill Ratio

Class action lawsuit filed against $MDPC alleging executives made false statements about book-to-bill ratio from April 2025 to February 2026, claiming overstated business prospects.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Medpace Stock Plunges 15.9% as Class Action Lawsuit Alleges Investor Guidance Misrepresentation

Medpace Holdings faces $MEDP class action lawsuit after stock plunges 15.9% due to book-to-bill ratio guidance miss: 1.04x actual vs. 1.15x guided.
MEDPclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Medpace Stock Plunges 16% Amid Book-to-Bill Guidance Miss; Class Action Lawsuit Filed

Class action lawsuit filed against $MEDP over missed Q4 2025 book-to-bill guidance. Stock fell 16% on February 9, 2026. Lead plaintiff deadline set for June 8, 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

MEDP Class Action Deadline Looms as Securities Fraud Investigation Targets Guidance Miss

Law firm Faruqi & Faruqi investigates Medpace for alleged securities fraud over misleading backlog statements. Stock plunged 15.9% after disappointing guidance, with June 8, 2026 deadline for lead plaintiff claims.
MEDPinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Medpace Stock Plunges 15.9% as Class Action Lawsuit Targets Misleading Guidance

Law firm Levi & Korsinsky files class action against Medpace Holdings over alleged false statements about backlog cancellations. Stock fell 15.9% after disappointing Q4 guidance.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Hit With Class Action Over Alleged Misleading Book-to-Bill Claims

Class action lawsuit filed against Medpace Holdings alleging executives made false statements about financial metrics from April 2025 to February 2026.
MEDPsecurities fraudclass action lawsuit
Investing.comInvesting.com··Jeffrey Neal Johnson

Kratos Defense Secures Airbus Partnership, Posts Strong Growth as Backlog Hits $1.57B

Kratos Defense partners with Airbus on AI-equipped Valkyrie drones while reporting 20% growth, record $1.57B backlog, and plans to quintuple production by 2028.
KTOSNOCEADSYdefense contractsbacklog growth
The Motley FoolThe Motley Fool··Brett Schafer

Redwire Stock Surges on Robust Backlog as Revenue Outlook Nearly Doubles

Redwire stock surges 20% on strong backlog expansion and 1.52x book-to-bill ratio. Company nearly doubles 2026 revenue guidance to $450-500M, though remains unprofitable.
RDWrevenue guidanceprofitability concerns